BTMD biote Corp.

Nasdaq Medicinal Chemicals & Botanical Products CIK: 0001819253
AI RATING
STRONG_SELL
88% Confidence

Investment Thesis

While the company maintains modest operating profitability (7% margin) and positive cash flow ($3.5M FCF), it faces severe financial distress with negative stockholders' equity of -$56.1M and a debt burden of $101.6M that dwarfs its $5.3M cash position. Declining revenue (-2.5% YoY), flat earnings growth, and poor liquidity ratios (quick ratio 0.58x) create material bankruptcy risk without significant operational turnaround or capital restructuring.

Strengths

  • + Positive operating cash flow of $3.9M demonstrates underlying business generates cash
  • + Operating margin of 7.0% shows core business operations are profitable
  • + Positive free cash flow of $3.5M (7.9% FCF margin) indicates cash generation capability

Risks

  • ! Negative stockholders' equity of -$56.1M indicates technical insolvency and bankruptcy risk
  • ! Debt burden of $101.6M is 2.3x total assets with only $5.3M in cash reserves creating refinancing and covenant risk
  • ! Revenue declining 2.5% YoY with flat net income growth signals operational deterioration
  • ! Quick ratio of 0.58x and current ratio of 1.29x indicate constrained liquidity and potential short-term solvency stress
  • ! Minimal equity cushion limits financial flexibility for operations, capex, or debt service

Key Metrics to Watch

Financial Metrics

Revenue
44.9M
Net Income
2.3M
EPS (Diluted)
$0.06
Free Cash Flow
3.5M
Total Assets
89.0M
Cash
5.3M

Profitability Ratios

Gross Margin N/A
Operating Margin 7.0%
Net Margin 5.1%
ROE N/A
ROA 2.6%
FCF Margin 7.9%

Balance Sheet & Liquidity

Current Ratio
1.29x
Quick Ratio
0.58x
Debt/Equity
N/A
Debt/Assets
153.9%
Interest Coverage
N/A
Long-term Debt
101.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-12T07:25:53.080253 | Data as of: 2026-03-31 | Powered by Claude AI